Lowering the Burden of Anemia in CKD: Looking to the Future with HIF-PHIs
Credit(s): 1.00 (60 min)
November 30, 2022 3:00 - 4:30 PM ET
MIPS Improvement Activity Under MACRA
Physicians – AMA PRA Category 1 Credit(s) ™
Physicians/ABIM MOC – ABIM MOC Point(s)
Nurses – Contact Hour(s)
Anemia in CKD is associated with increased risk of CKD progression, poor CV outcomes, decreased health-related quality of life, and increased healthcare resource utilization. Erythropoiesis-stimulating agents have been the standard of care for treating anemia in CKD but are associated with CV safety concerns; other therapies include red blood cell transfusions and iron administration but each potentially has severe adverse events.
Hypoxia-inducible factor-prolyl hydroxylase inhibitors (HIF-PHIs) are promising novel agents in development for treating CKD-associated anemia. These oral agents increase endogenous erythropoietin production, improve iron absorption and mobilization, and decrease hepcidin production in the liver.
Lowering the Burden of Anemia in CKD: Looking to the Future with HIF-PHIs will familiarize nephrology clinicians with the etiology of anemia in CKD, the effects on health outcomes, quality of life, and function, advantages and limitations of current management strategies and the economic advantages of their use, and the efficacy and safety data for HIF-PHIs in late-stage development for the management of CKD-related anemia.
Jointly provided by USFH and Rockpointe
This educational activity is supported by an educational grant from GlaxoSmithKline.
Clicking Start Activity indicates that you have reviewed the CME/CE information for this activity
Anemia in Patients with CVD and CKD: Current Management and Potential Role of HIF-PHIs
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.